12:00 AM
Feb 13, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Tocagen preclinical data

In a mouse model of glioblastoma, Toca 511 followed by 5-flucytosine (5-FC) eradicated brain tumors and increased survival to >180 days vs. 43 days for...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >